I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 13 studies | 26% ± 10% | |
| astrocyte | 12 studies | 37% ± 14% | |
| oligodendrocyte precursor cell | 9 studies | 28% ± 14% | |
| oligodendrocyte | 7 studies | 24% ± 8% | |
| microglial cell | 6 studies | 23% ± 7% | |
| epithelial cell | 6 studies | 27% ± 5% | |
| macrophage | 5 studies | 25% ± 6% | |
| retinal cone cell | 4 studies | 35% ± 4% | |
| adipocyte | 4 studies | 24% ± 5% | |
| ciliated cell | 4 studies | 21% ± 3% | |
| fibroblast | 4 studies | 20% ± 3% | |
| B cell | 3 studies | 21% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 18% ± 3% | |
| CD4-positive, alpha-beta T cell | 3 studies | 21% ± 4% | |
| CD8-positive, alpha-beta T cell | 3 studies | 19% ± 3% | |
| hepatocyte | 3 studies | 32% ± 12% | |
| GABAergic neuron | 3 studies | 40% ± 9% | |
| glutamatergic neuron | 3 studies | 42% ± 11% | |
| neural progenitor cell | 3 studies | 23% ± 4% | |
| club cell | 3 studies | 21% ± 6% | |
| endothelial cell of lymphatic vessel | 3 studies | 21% ± 3% | |
| type I pneumocyte | 3 studies | 21% ± 6% | |
| basal cell | 3 studies | 25% ± 7% | |
| goblet cell | 3 studies | 37% ± 18% |
